Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque
Open Access
- 8 July 2016
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 1-7
Abstract
Novel pro-inflammatory and anti-inflammatory derivatives from adipose tissue, known as adipokines, act as metabolic factors. The aim of this study was to analyse the secreted expression of different adipo/cytokines in secretomes of unstable carotid atherosclerotic plaque versus non-atherosclerotic mammary artery. We evaluated the secretion levels of adiponectin, visfatin, lipocalin-2, resistin, IL-6 and TNFR2 by ELISA in human secretomes from cultured unstable carotid atherosclerotic plaque (n = 18) and non-atherosclerotic mammary artery (n = 13). We also measured visfatin serum levels in patients suffering from atherosclerosis and in a serum cohort of healthy subjects (n = 16). We found that visfatin levels were significantly increased in unstable carotid atherosclerotic plaque secretome than in non-atherosclerotic mammary artery secretome. No differences were found with regard the other adipo/cytokines studied. Regarding visfatin circulating levels, there were no differences between unstable carotid atherosclerotic plaque and non-atherosclerotic mammary artery group. However, these visfatin levels were increased in comparison to serum cohort of healthy subjects. Of all the adipo/cytokines analysed, only visfatin showed increased levels in secretomes of unstable carotid atherosclerotic plaque. Additional human studies are needed to clarify the possible role of visfatin as prognostic factor of unstable carotid atherosclerotic plaque.Keywords
Funding Information
- Fondo de Investigación Sanitaria (FEDER) (PI13/00468)
- the Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 959)
- Universitat Rovira i Virgili (2010PFR-URV-B2-14)
This publication has 37 references indexed in Scilit:
- Relation of Osteoprotegerin , Visfatin and Ghrelin to Metabolic Syndrome in Type 2 Diabetic PatientsInternational Journal of Health Sciences (Qassim), 2015
- Plasma visfatin levels are associated with major adverse cardiovascular events in patients with acute ST-elevation myocardial infarctionClinical & Investigative Medicine, 2015
- Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular diseaseSingapore Medical Journal, 2014
- Association Between Visfatin Levels and Coronary Artery Disease in Patients with Chronic Kidney Disease2013
- Why is the mammary artery so special and what protects it from atherosclerosis?2013
- Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.Journal of Central South University. Medical sciences, 2013
- Advances in adipokinesMetabolism, 2012
- Adipokine Resistin Is a Key Player to Modulate Monocytes, Endothelial Cells, and Smooth Muscle Cells, Leading to Progression of Atherosclerosis in Rabbit Carotid ArteryJACC, 2011
- Visfatin causes endothelium-dependent relaxation in isolated blood vesselsBiochemical and Biophysical Research Communications, 2009
- Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism, 2006